Component analysis and network pharmacology of flavonoids in Sophora flavescens tissues at anthesis
10.16438/j.0513-4870.2022-1242
- VernacularTitle:苦参开花期不同组织黄酮类成分分析及其网络药理学研究
- Author:
Ming-yang WANG
1
,
2
;
Hui-fang SONG
3
;
Lu WANG
4
;
Jian-feng LI
3
;
Tian-zeng NIU
3
;
A-ke LIU
3
Author Information
1. School of Life Science, Shanxi Normal University, Taiyuan 030031, China
2. Department of Life Sciences, Changzhi University, Changzhi 046011, China
3. Department of Life Sciences, Changzhi University, Changzhi 046011, China
4. The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou 310006, China
- Publication Type:Research Article
- Keywords:
italic>Sophora flavescens;
metabolome;
flavonoid;
network pharmacology;
type 2 diabetes mellitus
- From:
Acta Pharmaceutica Sinica
2023;57(5):1317-1327
- CountryChina
- Language:Chinese
-
Abstract:
italic>Sophora flavescens is a traditional Chinese medicine rich in flavonoids and has wide application potential in drug development and clinical practice. In this study, a total of 227 flavonoids were detected among five tissues of S. flavescens during anthesis using widely targeted metabolomics techniques. There were 137 flavonoids shared by five S. flavescens tissues and 18 root-specific flavonoids. There were 156, 155, 156 and 150 differentially accumulated metabolites identified in stem, leaf, flower, and young pod, respectively, compared with root. Forty-seven potentially active flavonoid components in S. flavescens were identified using the PubChem and SwissADME databases. The 58 potential target proteins for these potentially active components were predicted to be important in the treatment of type 2 diabetes mellitus (T2DM) based on the SwissTargetPrediction and GeneCards database. These 58 target proteins were used to construct a protein-protein interaction network through the STRING database, from which we performed GO and KEGG functional enrichment analysis. The mechanisms by which S. flavescens flavonoids may be useful in the treatment of T2DM was further explored in a multi-level and systematic way based on a "component-target-pathway" network. Finally, ten key potentially effective components were identified and found to be mainly distributed in the roots, flowers, and pods, and their content varied significantly between tissues. The results predict that the key targets of S. flavescens flavonoids in the treatment of T2DM are AKT1, ESR1, EGFR, PIK3R1, TNF and PTGS2, and that they play a hypoglycemic role through the regulation of endocrine resistance, AGE-RAGE, the PI3K-Akt signaling pathway, EGFR tyrosine kinase inhibitor resistance and other signaling pathways. This analysis of the tissue distribution and network pharmacology of S. flavescens flavonoids provides a theoretical basis for further studies on S. flavescens metabolites, the rational development and utilization of the S. flavescens aboveground parts, and initiates a comprehensive exploration of the mechanisms by which S. flavescens can be used in the treatment of T2DM.
